-
-
-
-
-
-
-
Avidity Biosciences Reports Third Quarter 2025 Financial Results and Recent Highlights
-
-
-
-
-
-
-
Novartis CEO defends $12 billion deal for Avidity as 'appropriate risk to take'
-
-
-
-
-
-
-
Pre-Open Stock Movers 08/03: (OTLK) (TBIO) (HOLI) Higher; (CLX) (RNA) (KOPN) Lower (more...)
-
-
-
-
-
-
-
Prosensa Announces Voluntary Delisting and Advance Liquidation Distribution
-
-
-
-
-
-
-
BioMarin and Prosensa Announce Expiration of the Hart-Scott-Rodino Waiting Period for BioMarin's Proposed Acquisition of Prosensa
-
-
-
-
-
-
-
RBC Capital Comments on BioMarin (BMRN) Following Prosensa (RNA) Deal
-
-
-
-
-
-
-
Unusual 11 Mid-Day Movers 01/16: (RNA) (SRPT) (RENT) Higher; (BBY) (NUS) (AGI) Lower
-
1,158,072 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

